echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature: More mutations accumulate in the brains of Alzheimer's patients

    Nature: More mutations accumulate in the brains of Alzheimer's patients

    • Last Update: 2022-05-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Alzheimer's disease (AD) is a progressive neurodegenerative disease, but the specific events leading to neuronal dysfunction and death remain poorly understood


    A team of researchers from Boston Children's Hospital, the Broad Institute, Harvard Medical School and other institutions recently used single-cell sequencing technology to find an increase in somatic mutations in brain cells of patients with Alzheimer's disease


    The paper, "Somatic genomic changes in single Alzheimer's disease neurons," was published April 20 in the journal Nature


    Co-first author Michael Miller, a pathology researcher at Brigham and Women's Hospital, said: "Our findings suggest that AD neurons experience genomic damage that can place enormous stress on the cell and cause dysfunction


    The researchers used single-cell whole-genome sequencing to analyze pyramidal neurons from nine Alzheimer's patients, as well as frozen autopsy brain samples from 20 controls


    "Our findings suggest that the pathogenic mechanism of Alzheimer's disease may lead to genomic damage in neurons that progressively impairs their function," Miller and the other authors wrote


    In fact, Miller noted, "the vast amount of oxidative damage and somatic mutations we observed in neurons" may have contributed to the pathology of the disease


    In follow-up experiments, they used immunofluorescence microscopy to track 8-oxoG, a marker of oxidative stress, and found results that supported their idea


    The researchers believe that excitatory neurons in the brains of Alzheimer's patients accumulate genomic damage, and possibly permanent mutations, beyond levels that accumulate in general aging


    The authors caution that the current findings reflect the characteristics of patients with advanced Alzheimer's disease at death, while samples from intermediate-stage patients remain to be studied with single-cell sequencing methods


    Collectively, the results of these analyses will help researchers understand the biology behind Alzheimer's disease and reveal more alterations and mechanisms that will hopefully lead to new therapeutic strategies and targets


    "We wanted to elucidate how the mutations observed in Alzheimer's neurons lead to neuronal cell death," Miller said


    Original text retrieval

    Miller, MB, Huang, AY, Kim, J.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.